B. Riley Initiates Coverage on ConforMIS Inc to Buy

B. Riley Initiates Coverage on ConforMIS Inc(NASDAQ:CFMS). The shares have been rated Buy. The rating by B. Riley was issued on Sep 16, 2016.

In a different note, On Aug 9, 2016, Oppenheimer said it Maintains its rating on ConforMIS Inc. In the research note, the firm Raises the price-target to $12.00 per share. The shares have been rated ‘Outperform’ by the firm. On Aug 9, 2016, JP Morgan said it Maintains its rating on ConforMIS Inc. In the research note, the firm Raises the price-target to $8.00 per share. The shares have been rated ‘Neutral’ by the firm.

ConforMIS Inc (CFMS) made into the market gainers list on Thursdays trading session with the shares advancing 5.16% or 0.48 points. Due to strong positive momentum, the stock ended at $9.79, which is also near the day’s high of $9.8. The stock began the session at $9.36 and the volume stood at 2,48,369 shares. The 52-week high of the shares is $23.6173 and the 52 week low is $4.8. The company has a current market capitalization of $412 M and it has 4,21,27,152 shares in outstanding.

ConforMIS Inc(CFMS) last announced its earnings results on Aug 8, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $19.33M. Analysts had an estimated revenue of $18.02M. Earnings per share were $-0.34. Analysts had estimated an EPS of $-0.35.

Several Insider Transactions has been reported to the SEC. On Aug 19, 2016, Kenneth P Iii Fallon (director) sold 4,000 shares at $8.44 per share price.

ConforMIS Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient’s anatomy. It is engaged in offering a line of customized knee implants designed to restore the natural shape of a patient’s knee. The Company has sold over 30000 knee implants in the United States and Europe. It also launched iTotal PS the Company’s posterior-stabilized total knee replacement implant which addresses the largest segment of the knee replacement market. The Company’s products are available in the United States Germany and the United Kingdom. Its products are offered to orthopedic surgeons hospitals and other medical facilities and patients. The Company’s iFit technology platform includes three elements: iFit Design iFit Printing and iFit Just-in-Time Delivery.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

ConforMIS Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on ConforMIS Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.